Bioventus Inc. logo

Bioventus Inc. (BVS)

Market Closed
11 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
6. 81
-0.16
-2.3%
$
462.51M Market Cap
- P/E Ratio
0% Div Yield
314,290 Volume
- Eps
$ 6.97
Previous Close
Day Range
6.78 7.03
Year Range
6.02 14.38
Want to track BVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 21 days
Bioventus (BVS) Matches Q3 Earnings Estimates

Bioventus (BVS) Matches Q3 Earnings Estimates

Bioventus (BVS) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.

Zacks | 8 months ago
Are Medical Stocks Lagging Bioventus (BVS) This Year?

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Here is how Bioventus (BVS) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.

Zacks | 8 months ago
Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

Investors will likely focus on the sales performance of BVS across the Pain Treatments and Surgical Solutions franchises when it reports third-quarter results.

Zacks | 8 months ago
Bioventus Surges 73% in Three Months: Time to Buy the Stock?

Bioventus Surges 73% in Three Months: Time to Buy the Stock?

BVS generates encouraging returns, driven by rapid sales growth across the Pain Treatments and Surgical Solutions franchises.

Zacks | 8 months ago
Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

BVS' stock generates phenomenal returns, driven by double-digit revenue growth across the Pain Treatments and Surgical Solutions franchises.

Zacks | 9 months ago
Bull Of The Day: Bioventus (BVS)

Bull Of The Day: Bioventus (BVS)

This stock has seen 3 consecutive beats of the Zacks Consensus Estimate and also posted solid margin expansion.

Zacks | 10 months ago
Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript

Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript

Bioventus Inc. (NASDAQ:BVS ) Q2 2024 Earnings Conference Call August 7, 2024 8:03 AM ET Corporate Participants Dave Crawford - VP, IR & Treasurer Robert Claypoole - President and Chief Executive Officer Mark Singleton - Senior Vice President and Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Operator Good day, and welcome to the Bioventus Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.

Seekingalpha | 11 months ago
Here's Why You Should Consider Buying Bioventus (BVS) Stock

Here's Why You Should Consider Buying Bioventus (BVS) Stock

Here, we discuss some reasons why buying Bioventus (BVS) stock now may turn out to be a prudent move.

Zacks | 1 year ago
3 Stocks Under $10 With Mammoth Growth Prospects

3 Stocks Under $10 With Mammoth Growth Prospects

Finding good prospects is like hunting gold in the fast-paced world of investing. Three stocks stand out in this hunt, all under $10, with significant growth potential.

Investorplace | 1 year ago